EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

NCT02942160 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Edematous Fibrosclerotic Panniculopathy
Cellulite

Interventions

BIOLOGICAL: Collagenase Clostridium Histolyticum

Sponsor

Endo Pharmaceuticals